Diabetes enhances the intrahepatic vascular response to endothelin‐1 in cirrhotic rats: association with the ETA receptor and pERK up‐regulation

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Liver international (Print)

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/liv.12527PMID 24636620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute Kidney Injury in Cirrhosis.

  2015cited by this paper
• Diabetes Diminishes the Portal-Systemic Collateral Vascular Response to Vasopressin via Vasopressin Receptor and Gα Proteins Regulations in Cirrhotic Rats

  2013cited by this paper
• Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease.

  2012cited by this paper
• Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats

  2012cited by this paper
• The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study.

  2011cited by this paper
• Altered Endothelin-1 Signaling in Production of Thromboxane A2 in Kupffer Cells from Bile Duct Ligated Rats

  2009cited by this paper
• Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1.

  2009cited by this paper
• Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin‐1‐induced vasoconstriction via ETA receptors and ERK

  2008cited by this paper
• Effect of long-term streptozotocin-induced diabetes on coronary vasoconstriction in isolated perfused rat heart.

  2008cited by this paper
• Acute kidney injury in cirrhosis

  2008cited by this paper
• High glucose increases the expression of Gq/11alpha and PLC-beta proteins and associated signaling in vascular smooth muscle cells.

  2008cited by this paper
• Oral Glucose Tolerance Test Predicts Prognosis of Patients with Liver Cirrhosis

  2006cited by this paper
• Risk Factors for Renal Dysfunction in Type 2 Diabetes

  2006cited by this paper
• Dysregulation of the endothelial nitric oxide synthase-soluble guanylate cyclase pathway is normalized by insulin in the aorta of diabetic rat.

  2005cited by this paper
• Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension.

  2005cited by this paper
• Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats.

  2004cited by this paper
• Altered endothelin-1 induced contraction and second messenger generation in bovine retinal microvascular pericytes cultured in high glucose medium

  2004cited by this paper
• Effects of endothelin‐1 on portal‐systemic collaterals of common bile duct‐ligated cirrhotic rats

  2004cited by this paper
• Diabetes‐induced overexpression of endothelin‐1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP‐ribose) polymerase activation

  2003cited by this paper
• Endothelin-1--induced enhancement of coronary smooth muscle contraction via MAPK-dependent and MAPK-independent [Ca(2+)](i) sensitization pathways.

  2002cited by this paper
• The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough

  2002cited by this paper
• Endothelin-1–Induced Enhancement of Coronary Smooth Muscle Contraction via MAPK-Dependent and MAPK-Independent [Ca2+]i Sensitization Pathways

  2002cited by this paper
• G Protein Pathways

  2002cited by this paper
• Endothelin‐1 induces vasoconstriction on portal‐systemic collaterals of portal hypertensive rats

  2001cited by this paper
• Diabetes mellitus increases endothelin-1 gene transcription in rat kidney.

  2000cited by this paper
• Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes--an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis.

  2000cited by this paper
• Effects of vasopressin on portal‐systemic collaterals in portal hypertensive rats: Role of nitric oxide and prostaglandin

  1999cited by this paper
• Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo.

  1998cited by this paper
• The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide

  1997cited by this paper
• Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance

  1996cited by this paper
• Impaired microvascular response to graded coronary occlusion in diabetic and hyperglycemic dogs.

  1995cited by this paper
• Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia.

  1995cited by this paper
• Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis

  1994cited by this paper
• Nitric oxide modulates hepatic vascular tone in normal rat liver.

  1994cited by this paper
• The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery

  1994cited by this paper
• Small rodents.

  1994cited by this paper
• Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles.

  1993cited by this paper
• Endothelium‐dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin‐induced diabetic rats

  1992cited by this paper
• Diabetes Mellitus and the Vascular Endothelium

  1992cited by this paper
• Mechanism of impaired responses of cerebral arterioles during diabetes mellitus.

  1991cited by this paper
• Structural and functional origins of suppressed acetylcholine vasodilation in diabetic rat intestinal arterioles.

  1991cited by this paper
• Streptozotocin-induced diabetes mellitus lowers blood pressure in spontaneously hypertensive rat.

  1990cited by this paper
• Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta.

  1988cited by this paper

• Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress.

  2015cites this paper
• Hyperbaric Oxygen Treatment in a Diabetic Rat Model Is Associated with a Decrease in Blood Glucose, Regression of Organ Damage and Improvement in Wound Healing

  2014cites this paper